Showing results (1221-1230 of 1,511) with videos related to
Sort By:
Pageof 152
Nature Communications|April 7, 2023
Evaluating the evidence for exponential quantum advantage in ground-state quantum chemistrySeunghoon Lee, Joonho Lee, Huanchen Zhai, et al.Ecological Applications : a Publication of the Ecological Society of America|October 19, 2016
Nonnative forest insects and pathogens in the United States: Impacts and policy optionsGary M Lovett, Marissa Weiss, Andrew M Liebhold, et al.Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.European Journal of Heart Failure|June 29, 2018
Which patients with heart failure should receive specialist palliative care?Ross T Campbell, Mark C Petrie, Colette E Jackson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registryA Joan Levine, Jane C Figueiredo, Won Lee, et al.Gastro Hep Advances|August 12, 2024
Type 2 Diabetes and Risk of Early-Onset Colorectal CancerZitong Li, Hanyu Chen, Cassandra D L Fritz, et al.Psychiatry Research|July 30, 2024
From mood to use: Using ecological momentary assessments to examine how anhedonia and depressed mood impact cannabis use in a depressed sampleAmanda C Collins, Damien Lekkas, Cara A Struble, et al.Cancer|August 26, 2017
Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family RegistryJonathan M Kocarnik, Xinwei Hua, Sheetal Hardikar, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2025
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)A W Hahn, J Chahoud, W P Skelton, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2019
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitorsA Y Shah, R R Kotecha, E A Lemke, et al.Pageof 152